We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.83B
AUM Growth
+$68.6M
Cap. Flow
+$3.9M
Cap. Flow %
0.21%
Top 10 Hldgs %
57.7%
Holding
56
New
18
Increased
13
Reduced
11
Closed
13

Top Buys

Rank Stock Value
1
HOLX
Hologic
HOLX
+$139M
2
BIIB icon
Biogen
BIIB
+$125M
3
EW icon
Edwards Lifesciences
EW
+$69.3M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$63.8M
5
AET
Aetna Inc
AET
+$57.4M

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$106M
2
DXCM icon
DexCom
DXCM
+$93.9M
3
MDVN
MEDIVATION, INC.
MDVN
+$92.7M
4
ZBH icon
Zimmer Biomet
ZBH
+$58.3M
5
DGX icon
Quest Diagnostics
DGX
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 78.22%
2 Financials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$162B
$22.6M 1.23%
+270,680
New +$24M
PRAH
27
DELISTED
PRA Health Sciences, Inc.
PRAH
$22M 1.2%
526,700
+6,700
+1% +$309K
NBIX icon
28
Neurocrine Biosciences
NBIX
$16.9B
$20.5M 1.12%
450,000
-275,000
-38% -$12.7M
HCA icon
29
HCA Healthcare
HCA
$85.8B
$19.9M 1.08%
257,870
-592,130
-70% -$46.7M
MRK icon
30
Merck
MRK
$322B
$16.6M 0.91%
+301,981
New +$16.1M
DXCM icon
31
CALL
DexCom
DXCM
$31.7B
$15.9M 0.87%
+800,000
New +$13.6M
COLL icon
32
Collegium Pharmaceutical
COLL
$1.13B
$15.7M 0.86%
1,325,000
+100,000
+8% +$1.65M
BMY icon
33
Bristol-Myers Squibb
BMY
$132B
$15.6M 0.85%
211,940
-99,770
-32% -$7.05M
SYNH
34
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$15.3M 0.83%
400,000
-75,000
-16% -$3.3M
NBIX icon
35
CALL
Neurocrine Biosciences
NBIX
$16.9B
$14.1M 0.77%
+310,000
New +$14.3M
WAT icon
36
Waters Corp
WAT
$36.6B
$13.4M 0.73%
95,530
-102,509
-52% -$13.9M
PCRX icon
37
Pacira BioSciences
PCRX
$1.03B
$8.43M 0.46%
+250,000
New +$12.3M
ABUS icon
38
Arbutus Biopharma
ABUS
$847M
$7.86M 0.43%
2,258,300
+29,000
+1% +$123K
SPNE
39
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$6.53M 0.36%
623,100
+8,000
+1% +$96.5K
RPTP
40
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$5.65M 0.31%
+1,051,315
New +$5.39M
NTRA icon
41
Natera
NTRA
$37.7B
$3.51M 0.19%
290,600
+3,800
+1% +$42.3K
ALGN icon
42
Align Technology
ALGN
$12B
$3.36M 0.18%
+41,730
New +$3.19M
HSTO
43
DELISTED
Histogen Inc. Common Stock
HSTO
$2.18M 0.12%
5,296
+67
+1% +$32.8K
ACAD icon
44
Acadia Pharmaceuticals
ACAD
$4.37B
– –
-200,000
Closed -$5.59M
COR icon
45
Cencora
COR
$60.4B
– –
-171,240
Closed -$14.8M
IWM icon
46
PUT
iShares Russell 2000 ETF
IWM
$79.6B
– –
-700,000
Closed -$77.4M
MCK icon
47
McKesson
MCK
$100B
– –
-76,150
Closed -$12M
PFE icon
48
Pfizer
PFE
$142B
– –
-1,686,400
Closed -$47.4M
TEVA icon
49
Teva Pharmaceuticals
TEVA
$40.6B
– –
-419,760
Closed -$22.5M
ZTS icon
50
Zoetis
ZTS
$31.9B
– –
-479,820
Closed -$21.3M
1
2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q2 2016 Portfolio in Review

As of Q2 2016, HealthCor Management held 56 positions worth $1.83B, up 3.9% from $1.76B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

HealthCor Management's Q2 2016 filing shows 18 new, 13 increased, 11 reduced and 13 closed positions. Its largest new stake was Hologic: 4,000,000 shares worth $138M. The largest sale was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $106M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 78% a quarter earlier, followed by Financials.

  • HealthCor Management's largest Q2 2016 buy was Hologic: 4,000,000 shares worth $138M.
  • HealthCor Management added most to Edwards Lifesciences in Q2 2016, an estimated $69.3M increase.
  • HealthCor Management's biggest Q2 2016 reduction was DexCom, cutting an estimated $93.9M.
  • HealthCor Management fully exited MALLINCKRODT PUBLIC LIMITED COMPANY in Q2 2016, selling an estimated $106M.
  • HealthCor Management's ten largest holdings make up 58% of its $1.83B portfolio in Q2 2016.
  • HealthCor Management opened 18 new positions and closed 13 in Q2 2016.
  • HealthCor Management's portfolio value rose 3.9% quarter-over-quarter to $1.83B.

Based on HealthCor Management's 13F filing for Q2 2016, filed 15 Aug 2016.